Reports for BUPRENORPHINE

Ingredient

BUPRENORPHINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPRENORPHINE/NALOXONE 0.5MG 2MG TABLET Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203
TEVA-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2019-09-26 2020-01-24 94896
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2022-12-01 2022-12-22 176824
MYLAN-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2017-03-22 2017-04-12 3922
MYLAN-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2017-04-20 2019-09-18 7392
MYLAN-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Resolved 2017-03-16 2019-09-18 3089

Showing 31 to 37 of 37

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-BUPRENORPHINE/NALOXONE Discontinued 2019-09-17 2019-09-18 94044
MYLAN-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Discontinued 2019-09-17 2019-09-18 94048
BELBUCA 75MCG FILM, SOLUBLE Discontinued 2019-03-28 2019-04-02 79766
BELBUCA 150MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80230
BELBUCA 300MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80233
BELBUCA 450MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80236

Showing 1 to 6 of 6